Onbrez Breezhaler contains the active ingredient, indacaterol 150mcg, which is a bronchodilator used in the long-term treatment of chronic obstructive pulmonary disease (COPD).
Indacaterol is a long-acting beta 2 agonist and bronchodilator that binds to the beta 2 receptors in the bronchioles, allowing them to relax and open, making it easier to breathe. Symptoms such as shortness of breath, mucus production, chronic cough and tightness in the chest may be relieved for up to 24 hours.
Intended for once-a-day use the powder in Onbrez Breezhaler capsules is inhaled as part of a treatment plan to manage and improve the quality of life for those with COPD.